Penumbra CEO Adam Elsesser joins Let’s Talk Medtech to discuss the company's newest mechanical thrombectomy devices (Lightning Flash and Lightning Bolt), an ambitious revenue projection, and why failure is an acceptable option at his company.
Galen Robotics's CTO and co-founder Dave Saunders explains why true artificial intelligence in healthcare doesn't exist...yet.
Don't miss Cordis CEO Shar Matin talking about building a new company from a storied brand, M&A, and what to expect from Cordis now that it is privately owned and solely focused on medtech.
Tissium's co-founder and Chief Innovation Officer, Maria Pereira chronicles her journey into medtech and how a plan to mend heart tissue led to the formation of a company. Pereira co-invented Tissium's technology while she was a PhD student at Prof. Jeff Karp’s Laboratories. She has been recognized for her research by MIT Tech Review’s “35 Innovators Under 35” in 2014, as well as Forbes in its “30 under 30” selection in healthcare in 2015.
EY's Jim Welch stops by to discuss the EY Pulse of the Industry report and to discuss the state of M&A in medtech.
Dr. Jim Mault, BioIntellisense CEO, breaks down the rise of remote patient monitoring and explains why it’s time to drop the term. He also speaks about his time at Microsoft and Qualcomm.
Guardant Health's Co-Founder and CEO Helmy Eltoukhy discusses the company's growth and sheds light on the rapidly changing field of liquid biopsy.
BIOMEDevice Boston is fully loaded in 2022! Adrienne Zepeda, Group Event Director at Informa Markets - Engineering, gives us the scoop on why this is the show's biggest year ever!
The Massachusetts Medical Device Industry Council (MassMEDIC) has launched the Why Medtech campaign to build awareness of the medical device industry. MassMEDIC's Brian Johnson and Rachel Robinson joins us for this episode to discuss how people can take part in this campaign and why everyone has medtech story.
One of the current trends in the medtech industry involves companies expanding digital solutions. While digital innovation can be slow to progress in regulated industries like healthcare, GE Healthcare is changing the game with Edison Digital Health Platform , a vendor-agnostic hosting and data aggregation platform with an integrated artificial intelligence (AI) engine. Vignesh Shetty , Senior VP & General Manager of Edison AI And Platform at GE Healthcare, discusses why the digital platform...
Sometimes as a company grows and matures, the corporate identity it started out needs to change. Memic Innovative Surgery is the perfect example as the company has changed its name to Momentis Surgical. In addition the company has also changed the name of its technology from the Hominis Surgical System to Anovo Surgical. DVir Cohen, CEO of Momentis Surgical, discusses the name change and how the Anovo Surgical system stands out in the surgical robotics space.
Ruby Gadelrab, CEO and founder of MDisrupt, stops by Let’s Talk Medtech for a candid conversation about digital health, diversity, and working to create an atmosphere of inclusion in the space. Plus, she shares her professional experience.
It's no secret that Dexcom is on the rise. From commercials during the Super Bowl, to blockbuster products on the horizon, the company is reaching a new height of popularity in the continuous glucose monitoring space. Kevin Sayer, Dexcom CEO, talks about the company's new position the space and all the hype surrounding the upcoming G7 CGM sensor. He also gives his thoughts on where CGM technology is headed in this incredible, can't miss conversation.
It's hard to believe it's been more than 10 years ago since FitBit pioneered the fitness wearables market. As the technology has advanced, the lines between what is a consumer wellness device and what is a medical-grade wearable have begun to blur, with a number of companies sitting at the intersection of consumer wellness and medical-grade wearables. One such company is Movano. John Mastrototaro, CEO at Movano, joins the latest episode of Let's Talk Medtech to discuss that intersection of consu...
Something amazing is happening right now in the world of medtech. Devices are becoming mainstream and more consumer-friendly. With this new development, medical device companies have to think of a more consumer-friendly approach toward getting the message out about technologies. Nicole Osmer, Health+Commerce's CEO and founder, joins us for an insightful conversation on medtech branding.
In this Let's Talk Medtech Special, recorded at the IME West manufacturing tradeshow in Anaheim, CA April 12-14, 2022, we explore all aspects of the global supply chain crisis. You'll hear from multiple manufacturing experts who were at the show, in one succinct, narrative-style podcast episode.
Jijo James, MD, chief medical officer of medtech and global external innovation at Johnson and Johnson, talks with MD+DI News Editor Amanda Pedersen about medical device safety. He talks about the shift from reactive approaches to patient safety to a proactive approach. He also talks about how to handle situations where a use-related error is causing a safety concern, and how even those errors are the responsibility of the device manufacturer.
Embecta is now fully independent from Becton Dickinson & Co. Devdatt Kurdikar, Embecta's CEO talks about what that means going forward and his plans for the company. With its rich pedigree and newly-independent status, Embecta is truly the new/old kid on the block in diabetes care.
Ethan Drower, co-founder and Operating Partner of CiteMed drops by to talk about how his consulting firm is helping medtech companies navigate European Union Medical Device Regulation (EU MDR). Plus he gives some stellar tips on device regulation in other geographies too.
EY Americas Leader for Health Technology, Dr. Kaushik Bhaumik joins us for this episode of Let's Talk Medtech to discuss COVID-19's impact on the healthcare system. While the virus accelerated the adoption of technology in healthcare, it also illuminated existing gaps in digital care and leveraging patient data. And if not addressed, these gaps, along with other pressing healthcare issues like nursing shortages and the Great Resignation, will only further exacerbate healthcare’s existential prob...
It's been more than a month since Elizabeth Holmes, Theranos's founder and CEO, was found guilty on three counts of wire fraud and one count of conspiracy to commit wire fraud for lying to investors. There's no doubt that she has a mystique surrounding her that invites conversation. Hulu even recently released a limited series starring Amanda Seyfried as Holmes, which documents the rise and fall of Theranos. A special panel of medtech veterans discusses the mystique surrounding Holmes and the im...
ZimVie's CEO Vafa Jamali joins Let's Talk Medtech in an exclusive interview about how the company is poised to transform the dental and spine markets. The company has now been completely spun out from Zimmer Biomet and is trading on the Nasdaq. With strong leadership and a strong product portfolio, ZimVie is poised to be one of the breakout companies of the year in medtech.
It's American Heart Month & Cleerly's Dr. James Min shows how the company is using artificial intelligence to change the way we diagnose cardiovascular disease.
Varian is changing the way we look at and treat cancer. Dr. Deepak 'Dee' Khuntia joins us for an incredible conversation about Varian's strategy in the fight against cancer.
A look at what's in store for medtech deals this year. Will 2022 be known as the year of Medtech M&A? Looks like it. EY's John Babitt joins us for a riveting conversation about EY's Annual M&A Firepower Report.
Omicron has caused quite a disruption in both pharma and medtech. Derron Stark EY-Parthenon Partner, Principal, Strategy Transactions, speaks about these supply chain issues.
Dr. Lishan Aklog wears multiple hats. He's the CEO of both PavMed and Lucid Diagnostics. Being a CEO of two companies during the pandemic can be tough at times, but Dr. Aklog's biggest challenge is getting out the awareness of how some instances of GERD can lead to Esophageal Cancer. Dr. Aklog stops by for an amazing conversation on how Lucid Diagnostics is making an impact in the detection of Esophageal Cancer.
Paul Grand, MTI's CEO and Glenn Synder, Deloitte's Principle medtech practice leader discuss startups.
Allisa Song discusses her role as CEO of Nanodropper, while still attending medical school.
Is medtech’s pulse strong? EY’s Jim Welch discusses the ‘industry's pulse in this all-new episode.
